血液静止策略和水凝的最新进展,用于管理不受控制的出血
Lijun Liu1, Rui Jing1, Lei Yao1
1Department of Pharmacy, Medical Supplier Center, Chinese PLA General Hospital, Beijing 100853, China.
ACS applied bio materials
|January 2, 2025
概括
由于其生物相容性和可调节性质,先进的静血水凝可以有效控制出血. 本综述详细介绍了它们的设计,机制和用于血液管理的临床应用.
科学领域:
- 生物材料科学 生物材料科学
- 医疗工程 医疗工程
- 血液静止研究 血液静止研究
背景情况:
- 出血仍然是一个关键的医疗挑战,需要先进的静血材料.
- 静血水凝正在成为控制出血的有希望的解决方案.
- 关键特征包括生物相容性,可调节的机械性能和卓越的静血疗效.
研究的目的:
- 为血液静止水凝提供全面的审查,以快速有效地控制出血.
- 专注于这些水凝的设计原理和潜在的静血机制.
- 分析最近的进展,临床试验应用,挑战和未来的潜力.
主要方法:
- 血液静止水凝研究的文献综述.
- 分析水凝设计策略和静血机制.
- 综合关于临床应用和未来前景的信息.
主要成果:
- 静血水凝在控制各种类型的出血方面表现出显著的潜力.
- 特定的设计考虑因素会影响水凝的性能和静血活性.
- 最近的临床试验凸显了这些材料的逐渐转化.
结论:
- 静血水凝是控制出血的重要生物材料之一.
- 在水凝设计的进一步创新对于开发临床适用的静血剂至关重要.
- 持续的研究将加强它们在生物医学应用和患者治疗结果中的作用.
相关概念视频
Introduction to Hemostasis
5.4K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
5.4K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
607
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
607
Extrinsic and Intrinsic Pathways of Hemostasis
5.3K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
5.3K
Vascular Spasm
1.2K
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
1.2K
Formation of the Platelet Plug
4.2K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
4.2K
Esophageal Varices-II: Clinical Features and Management
46
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
46


